Company Filing History:
Years Active: 1993-2004
Title: Setsuko Ojima: Innovator in Enzyme Technology
Introduction
Setsuko Ojima is a notable inventor based in Fujisawa, Japan. He has made significant contributions to the field of enzyme technology, holding a total of 6 patents. His work primarily focuses on recombinant enzymes that have applications in various biochemical processes.
Latest Patents
One of his latest patents involves alcohol and aldehyde dehydrogenase. This invention is directed to recombinant enzymes that exhibit alcohol and aldehyde dehydrogenase activity. The enzymes comprise one or more recombinant polypeptides selected from a specific group of polypeptides identified by SEQ ID NO 5, SEQ ID NO 6, SEQ ID NO 7, and SEQ ID NO 8. Additionally, it includes chimeric recombinant polypeptides that combine at least two of these amino acid sequences. The enzymatic polypeptides are designed to facilitate the production of aldehydes, ketones, or carboxylic acids, specifically targeting 2-keto-L-gulonic acid, which is an intermediate for the production of L-ascorbic acid (vitamin C). Another significant patent involves the D-sorbitol dehydrogenase gene, which encodes proteins with D-sorbitol dehydrogenase activity. This patent also covers vectors and recombinant organisms containing such polynucleotides, along with methods for producing D-sorbitol dehydrogenase and L-sorbose.
Career Highlights
Throughout his career, Setsuko Ojima has worked with prominent companies such as Roche Vitamins Inc. and Hoffmann-La Roche Inc. His experience in these organizations has contributed to his expertise in enzyme technology and biochemistry.
Collaborations
Setsuko has collaborated with notable individuals in his field, including Tatsuo Hoshino and Masako Shinjoh. Their combined efforts have further advanced the research and development of innovative enzyme applications.
Conclusion
Setsuko Ojima's contributions to enzyme technology and his innovative patents highlight his role as a significant inventor in the field. His work continues to impact the biochemical industry and pave the way for future advancements.